Global Marine Pharmaceuticals Market Growth 2023-2029

Global Marine Pharmaceuticals Market Growth 2023-2029

Product Code:455317

Published Date: Feb 08,2023

Pages: 114

Region: Global

Category: Pharma & Healthcare

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.

Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.

LPI (LP Information)' newest research report, the “Marine Pharmaceuticals Industry Forecast” looks at past sales and reviews total world Marine Pharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Marine Pharmaceuticals sales for 2023 through 2029. With Marine Pharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Marine Pharmaceuticals industry.

This Insight Report provides a comprehensive analysis of the global Marine Pharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Marine Pharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Marine Pharmaceuticals market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Marine Pharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Marine Pharmaceuticals.

The global Marine Pharmaceuticals market size is projected to grow from US$ 28860 million in 2022 to US$ 52140 million in 2029; it is expected to grow at a CAGR of 52140 from 2023 to 2029.

Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.

North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent. 
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.

This report presents a comprehensive overview, market shares, and growth opportunities of Marine Pharmaceuticals market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Drugs
    Health Supplement

Segmentation by application
    Hospital & Clinic
    Pharmacy
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Seattle Genetics
    DSM
    Eisai Co
    Takeda
    BASF
    Amway
    Pfizer
    Pelagia (EPAX)
    Pharma Mar SA
    Croda
    GNC
    GSK
    TerSera Therapeutics
    Nordic Naturals
    Carlson Labs

Key Questions Addressed in this Report
What is the 10-year outlook for the global Marine Pharmaceuticals market?
What factors are driving Marine Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Marine Pharmaceuticals market opportunities vary by end market size?
How does Marine Pharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?